A-262
A chemical compound belonging to the Novichok family of nerve agents
A-262 is a chemical compound that belongs to the Novichok family of nerve agents. These agents were developed in the Soviet Union during the Cold War and are known for their high toxicity and potential use in chemical warfare.
Chemical Structure
A-262 is an organophosphate compound, which means it contains phosphorus as part of its chemical structure. The specific structure of A-262 includes a phosphorus atom bonded to various organic groups, which contribute to its potency as a nerve agent.
Mechanism of Action
Like other nerve agents, A-262 functions by inhibiting the enzyme acetylcholinesterase. This enzyme is responsible for breaking down the neurotransmitter acetylcholine in the synaptic cleft. Inhibition of acetylcholinesterase leads to an accumulation of acetylcholine, resulting in continuous stimulation of muscles, glands, and central nervous system structures.
Toxicity
A-262 is highly toxic, with effects similar to other nerve agents such as sarin and VX. Exposure to even small amounts can be fatal, and symptoms of poisoning include muscle twitching, respiratory distress, convulsions, and loss of consciousness.
History and Development
The development of A-262 and other Novichok agents was part of a secret Soviet program aimed at creating more potent chemical weapons that could evade detection by international monitoring systems. The existence of these agents was revealed by Vil Mirzayanov, a former Soviet scientist, in the 1990s.
Detection and Protection
Detection of A-262 and other Novichok agents requires specialized equipment capable of identifying trace amounts of these compounds. Protective measures include the use of personal protective equipment (PPE) such as gas masks and protective suits, as well as the administration of antidotes like atropine and pralidoxime.
Related pages
Gallery
-
Chemical structure of A-262
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian